Cystic breast lymphangioma by Waqar, S N et al.
eCommons@AKU
Department of Biological & Biomedical Sciences Medical College, Pakistan
October 2004
Cystic breast lymphangioma
S N. Waqar
Aga Khan University
H Khan
Aga Khan University
S F. Mekan
Aga Khan University
N Kayani
Aga Khan University, naila.kayani@aku.edu
A J. Raja
Aga Khan University, asad.raja@aku.edu
Follow this and additional works at: https://ecommons.aku.edu/pakistan_fhs_mc_bbs
Part of the Biochemistry Commons, Pathology Commons, and the Surgery Commons
Recommended Citation
Waqar, S. N., Khan, H., Mekan, S. F., Kayani, N., Raja, A. J. (2004). Cystic breast lymphangioma. Journal of Pakistan Medical
Association, 54(10), 531-533.
Available at: https://ecommons.aku.edu/pakistan_fhs_mc_bbs/445
Case Reports
Cystic Breast Lymphangioma
S. N. Waqar, H. Khan*, S. F. Mekan, N. Kayani**
Departments of Biological and Biomedical Sciences, Surgery* and Pathology and Microbiology**, The Aga Khan University, Karachi.
Introduction
Cystic lymphangioma of the breast is a rare benign
lymphatic tumor. Lymphangiomas consist of dilated lymph
channels lined by endothelium. Possible etiological factors
include blockage of the lymphatic channels with secondary
dilatation, congenital weakness of the lymphatic wall or
proliferation of lymphatic vessels.1 These lesions enlarge
over time by the collection of fluid and the budding of pre-
existing spaces. These cystic spaces communicate with
large dermal lymphatics and subepidermal vesicles, but not
with the regional lymphatic system.
The morphology of the lesions varies according to
the character of the surrounding connective tissue. They may
range from cysts in loose areolar tissue to superficial vesicles
in dense fibrous tissue, features of both may coexist.
Superficially they appear as plaques of grouped,
deep-seated, thick-walled vesicles with a warty appearance
and which may contain hemorrhagic fluid. New crops can
develop in areas of previously unaffected skin.
Histopathologically, hyperplasia, hyperkeratosis, and papil-
lomatosis of the epidermis overlying the vesicles are seen.2
These vesicles are painless in contrast to the painful vesicu-
lar eruption of herpes zoster, which follow a dermatomal dis-
tribution, having a short clinical course. Tzanck smear, direct
fluorescent antibody, culture, and biopsy would be useful in
the latter. We present a case of a 24-year-old woman with a
congenital right breast mass diagnosed as a cystic breast lym-
phangioma. The development and clinical presentation of
breast lymphangiomas is discussed with an emphasis on
rational approach to diagnosis and treatment of these diffi-
cult lesions. 
Case Report
A 24-year-old lactating Afghani woman presented
with a 1 month history of high grade fever, chills and rigors 
along with painful enlargement of a pre-existing right breast
lump. The lump had been present since birth and had grad-
ually enlarged over time.
On examination, the right breast and axillary tail
were diffusely enlarged, appearing to be approximately
three times the size of the other breast. On palpation the
mass was firm, nodular and mobile with respect to underly-
ing tissues but attached to overlying skin which was edema-
tous (peau d' orange) with prominent veins. On the under
surface of the breast were grouped thick-walled vesicles,
not conforming to any dermatomal distribution. Some of
these vesicles contained brownish hemorrhagic fluid.
Preliminary diagnosis of a congenital breast mass with
superimposed acute mastitis was made.
The complete blood count was within normal limits
and serial blood cultures were negative. Ultrasound of the
right breast showed heterogenous echotexture, with irregu-
lar, multiple cystic areas and increased soft tissue vascular-
ity. No abscess collection was seen. MRI further revealed a
mixed solid and cystic lesion infiltrating the breast
parenchyma. Incisional biopsy revealed cystic lesions, lined
by flat endothelium, with lymphocytes in the interstitium,
consistent with the diagnosis of lymphangioma.
She was given analgesia, appropriate antibiotic ther-
apy and lactation suppression. The mass was surgically
resected after management of the acute mastitis.
The breast specimen of the patient measured
25x20x7cm. The skin surface had multiple nodular projec-
tions and the cut surface revealed irregular cystic areas with
spongy appearance, involving the whole tissue. Skeletal
muscle was attached to the deep margin. Microscopic exam-
ination revealed a neoplastic lesion composed of dilated
lymphatic channels lined by a single layer of flattened cells.
These were separated in areas by breast parenchyma.
Lymphoid aggregates were seen.
Discussion
Cystic lymphangioma of the breast is a rare benign
lymphatic tumor; only 10 cases have been reported in the
past 30 years. Clinically, most are evident before the age of
2 years. Rarely, they may be detected later on in adoles-
cence or adulthood on incidental radiological screening. 
In this case, lymphangioma was diagnosed on the
basis of clinical, radiological and histopathologic evidence.
Rare cases of breast lymphangiomas have also been discov-
ered on routine screening mammography.3 Ultrasound is
more useful in young women with dense breasts and differ-
entiates solid from cystic masses.4 MRI demonstrates accu-
rately the depth and extent of the tumor which would dictate
therapy.5 However, the confirmatory diagnosis of lymphan-
gioma is made on the basis of histopathology. 
Lymphangiomas are treated for cosmetic and func-
tional reasons. Failure to treat may result in secondary com-
plications of infection and hemorrhage. Malignant degener-
ation into squamous cell carcinoma6 in a long-standing
lesion, and lymphangiosarcoma7 at the site of irradiated
lymphangioma circumscriptum have been reported.
Treatment options are many, with varying success
and recurrence rates. The choice depends on depth and loca-
tion of the lesion along with the patient's age and general
health. Steroid injections and sclerosants are losing popular-
ity owing to high rate of recurrence.8 In such cases, subse-
quent surgery becomes technically difficult owing to scle-
rosed tissue. Carbon dioxide laser yields functionally and
cosmetically acceptable results by vaporizing some of the
surface lymphatic vessels.9 Streptococcal lysin (OK-432) is
a biological response modifier which induces local inflam-
matory cytokines that increase endothelial cell permeability,
lymph drainage and flow leading to shrinkage of the cystic
spaces.10 It can be used alone or to make the lesion more
amenable to surgery. Wide surgical excision of the cisterns
facilitated by MRI is the most effective treatment modality,
which was also the treatment of choice in this patient. For
poor surgical candidates, radiotherapy is the option consid-
ered.
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